drug

Buprenorphine 0.15 MG [Belbuca]

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by University of California Riverside at C.I. Trials, Inc.-Inland Empire
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Investigational (via trials)
SchizophreniaSchizophrenia

Trials

1
Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
NCT05778591Phase 2Recruiting

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
trial
Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
PHASE2
trial
indication
Schizophrenia
indication
Schizophrenia
indication